-+ 0.00%
-+ 0.00%
-+ 0.00%

Truist Securities Maintains Hold on Evolent Health, Lowers Price Target to $6

Benzinga·08/12/2026 17:26:36
Listen to the news
Truist Securities analyst Jailendra Singh maintains Evolent Health (NYSE:EVH) with a Hold and lowers the price target from $7 to $6.